Coartem® Dispersible. An innovation in treating children with malaria.

• From: Department for International Development
• Published: 1 January 2009

• Document Type: Briefing
• Theme: Health
• Authors: Medicines For Malaria Venture (MMV)

Abstract

This fact sheet provides information about Coartem® Dispersible, a new paediatric formulation of Coartem® (artemether/lumefantrine) developed by MMV and Novartis. It is the first artemisinin-based combination therapy (ACT) developed especially for children with malaria.

Citation

Links

Coartem® Dispersible. An innovation in treating children with malaria.

Published 1 January 2009